Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide study
The use of AS greatly increased over time, not least amongst younger healthy men, whereas the use of deferred treatment was relatively stable. AS has been increasingly accepted as a safe approach for localised, favourable-risk prostate cancer.
Authors
- Pär Stattin (ORCID: https://orcid.org/0000-0002-8306-0687)
- Ola Bratt (ORCID: https://orcid.org/0000-0002-9198-9445)
- Anna Bill‐Axelson (ORCID: https://orcid.org/0000-0002-4559-1217)
- Hampus Hållberg (ORCID: https://orcid.org/0009-0001-3185-0687)
- Anders Berglund (ORCID: https://orcid.org/0000-0003-3698-9861)
- Jovana Maljkovic (ORCID: https://orcid.org/0009-0001-3670-5980)
Institutions
- Uppsala University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Scandinavian Journal of Urology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.2340/sju.v59.40123
- Citations
- 8
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.35
Funders
- Västra Götalandsregionen